Showing 1521-1530 of 2127 results for "".
Treatment Considerations in the Short- and Long-Term Management of Plaque Psoriasis: Is There A Role for Tazarotene?
https://practicaldermatology.com/topics/psoriasis/treatment-considerations-in-the-shortandlong-term-management-of-plaquepsoriasis-is-there-a-role-for-tazarotene/23041/Tazarotene is almost a forgotten entity in management of psoriasis, despite quality data showing it can be both tolerable and effective—when used appropriately.Addressing Antibiotic Resistance in Acne Regimens
https://practicaldermatology.com/topics/general-topics/addressing-antibiotic-resistance-in-acne-regimens/21248/As antibiotic resistance increasingly poses significant challenges, dermatologists should make necessary adjustments in the treatment of acne.Revisiting Facial Seborrheic Dermatitis: A New Therapeutic Option
https://practicaldermatology.com/topics/general-topics/PD0109_05-php/22892/A popular topical agent offers anti-inflammatory, antibacterial, and sebosuppressive effects that could prove useful for management of seborrheic dermatitis.Skin Bugs and Travel Bugs: An Update for Clinicians
https://practicaldermatology.com/topics/general-topics/skin-bugs-and-travel-bugs-an-update-for-clinicians/20601/Skin disease is the third most common medical problem that travelers encounter. Heres' what you need to know about diagnosis and treatment.Digital Innovation to the Rescue: The Future of Electronic Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/digital-innovation-to-the-rescue-the-future-of-electronic-prior-authorization-in-dermatology/20467/Adopting new technology to reduce paperwork, costs, and burnout as well as improve patient care.Updating Approaches to Psoriasis
https://practicaldermatology.com/topics/psoriasis/evaluating-the-state-of-psoriasis-care/21660/Recent guidelines from the National Psoriasis Foundation point to new directions in research and therapy that will continue to shape psoriasis therapy.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Psoriasis in Sensitive Areas
https://practicaldermatology.com/topics/psoriasis/psoriasis-in-sensitive-areas/23868/Treatment updates and tips for communicating with patients.